Description
May 22, 2024 | 12:00-1:00pm
Description:
This panel discussion will explore the ME CDC’s “Safe Sleep” Campaign for infants and how SUD treatment providers can support key Safe Sleep messaging with their patients. Panelists will highlight recent patterns and trends in sleep-related harm to infants, and the science behind how safe sleep habits can impact infant Sudden Death. Panelists will then outline the key role that SUD treatment providers can play in making practical recommendations to patients and families with SUD who are caring for infants. This webinar will explore the unique challenges and stigma faced by parents with SUD and provide recommendations for providers on how to meet the unique needs of their patients. Panelists will also highlight local resources and strategies to assist parents in providing a safe sleeping environment for their children.
Learning Objectives:
- Learn Safe Sleep standards, and about the Safe Sleep Campaign.
- Examine effective ways to communicate these standards to patients with SUD.
- Explore techniques to reduce risk of an unsafe sleep environment, available resources, and the 5 S’s
Presenters:
Meredith Jackson, MD
Meredith Jackson, MD is a Newborn and Pediatric Hospitalist at the Barbara Bush Children’s Hospital at Maine Medical Center and has been in practice since 2015. As the Director of the Newborn Teaching Service and the head of Safe Sleep initiatives at Maine Medical Center, she takes a strong interest in preventative newborn care. Originally from Massachusetts, she attended medical school at the University of Vermont and did pediatrics residency here in Maine. She has two young children and loves being so close to the ocean.
Alane O’Connor, DNP
Alane O’Connor, DNP is the director of perinatal addiction medicine at Maine Medical Center and is the medical advisor of the Maine Maternal Opioid Misuse (MaineMOM) Initiative, a 5-year, $5 million federal grant to expand access to substance use treatment for pregnant and postpartum individuals in Maine. She also co-chairs Maine’s Opioid Response Clinical Advisory Committee, which advises the Governor’s opioid response director on clinical and public policy issues. Dr. O’Connor has more than 15 years of experience in addiction medicine in a variety of settings including the design and implementation of an extended-release buprenorphine pilot at Somerset County Jail, rapid access to substance use treatment in emergency departments through Maine Medical Association’s Project RISE, as well extensive experience caring for pregnant patients with substance use disorder in both the inpatient and outpatient settings. She lectures regionally and nationally and has trained more than 100 family medicine and obstetric resident physicians. She is a core faculty member of Maine’s only addiction medicine fellowship program. Finally, she has published numerous peer reviewed articles on maternal and infant outcomes of substance exposed pregnancies including the related child welfare implications as well as the care of incarcerated pregnant patients
Lisa Letourneau, MD, MPH (Facilitator)
Dr. Lisa Letourneau is an experienced physician leader and passionate advocate for health care system delivery change, with particular interests in advancing primary care, behavioral health integration, rural health, value-based payment, and efforts to address the opioid epidemic. She currently serves as Senior Advisor to Maine DHHS Commissioner Lambrew, advising on health care delivery system change efforts. She helped to support several aspects of Maine’s response to the COVID-19 pandemic, including provider education and outreach related to testing, vaccination, and therapeutic efforts. She currently helps to lead the DHHS Rural Health Transformation initiative, as well as providing support to clinical aspects of Maine’s Opioid Response Strategic Plan and MaineCare’s value-based payment efforts. Prior to joining the DHHS team, Dr Letourneau served as Executive Director for Maine Quality Counts and previously served as Senior Director of Clinical Integration for MaineHealth.
Kimberly Gosselin, LSW-c, OQMHP
Audience:
Prescribing clinicians and their teams
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and CCSME. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
The Maine Medical Education Trust designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
*Nurses and Nurse Practitioners will be awarded a certificate of participation with a maximum of 1 AMA PRA Category 1 Credit™.
Contact Hours
1 contact hours for social workers, licensed clinical professional counselors, and behavioral health professionals.
1 Category I contact hours for psychologists. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.
1 contact hours for Alcohol and Drug Counselors pending approval by the Maine Board of Alcohol and Drug Counselors
1 contact hours CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
